Education
About Us
Working with TipRanks
Follow Us
MoonLake Immunotherapeutics (MLTX)
NASDAQ:MLTX
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -2.62M | $ 0.00 | $ 0.00 | $ 0.00 | $ -4.97K |
| Operating Income | $ -244.83M | $ -143.09M | $ -54.12M | $ -65.06M | $ -53.58M |
| EBITDA | $ -219.85M | $ -141.71M | $ -53.75M | $ -64.90M | $ -53.63M |
| Net Income | $ -227.32M | $ -118.94M | $ -36.01M | $ -49.97M | $ -53.64M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 393.97M | $ 448.03M | $ 511.01M | $ 72.11M | $ 8.04M |
| Total Assets | $ 424.43M | $ 477.93M | $ 526.54M | $ 76.84M | $ 9.68M |
| Total Debt | $ 75.71M | $ 2.83M | $ 3.70M | $ 282.58K | $ 15.00M |
| Net Debt | $ -258.81M | $ -177.60M | $ -447.47M | $ -39.22M | $ 6.96M |
| Total Liabilities | $ 119.95M | $ 24.54M | $ 13.05M | $ 8.08M | $ 21.33M |
| Stockholders' Equity | $ 304.48M | $ 446.83M | $ 495.68M | $ 48.90M | $ -11.65M |
| Cash Flow | |||||
| Free Cash Flow | $ -196.04M | $ -117.11M | $ -43.06M | $ -55.91M | $ -35.23M |
| Operating Cash Flow | $ -196.01M | $ -116.59M | $ -42.78M | $ -55.89M | $ -35.18M |
| Investing Cash Flow | $ 202.99M | $ -205.60M | $ -25.18M | $ -32.34M | $ -50.71K |
| Financing Cash Flow | $ 146.00M | $ 51.31M | $ 479.70M | $ 119.69M | $ 43.26M |